Evidence map›Paper›PMID 22768276›Full record

ArticlePloS one2012

Huntingtin fragments and SOD1 mutants form soluble oligomers in the cell.

Yang-Nim Park, Xiaohong Zhao, Mark Norton, J Paul Taylor, Evan Eisenberg, Lois E Greene

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Atomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (ALS).Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yang-Nim ParkLaboratory of Cell Biology, National Heart Lung Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Xiaohong Zhao
Mark Norton
J Paul Taylor
Evan Eisenberg
Lois E Greene

Funding

Role of molecular chaperones in protein folding diseasesZIAHL000516 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI GREENE, LOIS · 2009 to 2022
$19.6M
Intramural NIH HHS
6 · The paper itself

Abstract

Diffusion coefficients of huntingtin (Htt) fragments and SOD1 mutants expressed in cells were measured using fluorescence correlation spectroscopy. The diffusion mobilities of both non-pathological Htt fragments (25 polyQs) and pathological Htt fragments (103 polyQs) were much slower than expected for monomers suggesting that they oligomerize. The mobility of these fragments was unaffected by duration of expression or by over-expression of Hsp70 and Hsp40. However in cells with HttQ103 inclusions, diffusion measurements showed that the residual cytosolic HttQ103 was monomeric. These results suggest that both non-pathological and pathological Htt fragments form soluble oligomers in the cytosol with the properties of the oligomers determining whether they cause pathology. SOD1 with point mutations (A4V, G37R, and G85R) also had slower diffusional mobility than the wild-type protein whose mobility was consistent with that of a dimer. However, the decrease in mobility of the different SOD1 mutants did not correlate with their known pathology. Therefore, while soluble oligomers always seem to be present under conditions where cell pathology occurs, the presence of the oligomers, in itself, does not determine the extent of neuropathology.

Indexed as

AnimalsBlotting, WesternCell ExtractsDiffusionGreen Fluorescent ProteinsHeLa CellsHumansMiceMutant ProteinsNerve Tissue ProteinsPeptide FragmentsPeptidesPoint MutationProteasome Endopeptidase ComplexProteasome InhibitorsProtein Structure, QuaternaryCell ExtractsGreen Fluorescent ProteinsMutant ProteinsNerve Tissue ProteinsPeptide FragmentsPeptidespolyglutamineProteasome Endopeptidase ComplexProteasome InhibitorsSOD1 protein, humanSod1 protein, mouseSuperoxide DismutaseSuperoxide Dismutase-1

Identifiers

PMID22768276
PMCPMC3386994

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.